Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Kristen Pettit

Clinical Associate Professor

University of Michigan

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States Professors in Medical Imaging Medical Imaging professors in United States

Articles (20)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (12)

Vikas Gupta

CANADA

View details

Anao Zhang

Behar Endowed Associate Professor in Psychosocial Oncology

University of Michigan

UNITED STATES

View details

Lydia Benitez

University of Michigan

UNITED STATES

View details

Russell J.H. Ryan

Associate Professor

University of Michigan Medical School

UNITED STATES

View details

Lili Zhao

Professor

Northwestern University

UNITED STATES

View details

Florian Heidel

Professor, Director and Chair

Hannover Medical School

GERMANY

View details

Malathi Kandarpa

University of Michigan

UNITED STATES

View details

gary luker

University of Michigan

UNITED STATES

View details

Harry P. Erba

UNITED STATES

View details

Brian Ross

Professor

University of Michigan

UNITED STATES

View details

N Lynn Henry

University of Michigan

UNITED STATES

View details

Sunil Iyer

Columbia University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kristen Pettit

Research Interests

Make your next move.

Explore related searches

Articles (20)

On-Scanner Correction of Gradient Nonlinearity Bias for Accurate Assessment of Diffusion Heterogeneity Across Bone Sites in Myelofibrosis Patients

Impact of Chemotherapy Educational Videos for Patients with Acute Myeloid Leukemia

Therapeutic outcomes of patients with acute erythroid leukemia treated with hypomethylating agents

Fat Fraction MRI for Longitudinal Assessment of Bone Marrow Heterogeneity in a Mouse Model of Myelofibrosis

Ziftomenib in Relapsed or Refractory NPM1 -Mutated AML

Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapy

Secondary review of extramural hematopathology cases for patients referred to an academic center: The increasing importance of subspecialized hematopathology practice.

Identifying Adolescent and Young Adults' Preferences for Oncology Symptom Management Clinical Trial Participation

A deep learning aided bone marrow segmentation of quantitative fat MRI for myelofibrosis patients

A phase 2, open-label study of the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of DISC-3405 in participants with polycythemia vera (PV)

Comprehensive analyses of patient-reported outcomes from the phase 3 VERIFY study of rusfertide or placebo plus current standard of care for polycythemia vera

Effect of avapritinib on skin lesions in patients with advanced systemic mastocytosis using a novel, artificial intelligence-based technology

Quantitative MRI Assessment of Bone Marrow Disease in Myelofibrosis: A Prospective Study

RALLY MF: A phase 2 Study of DISC-0974, an anti-hemojuvelin antibody, in patients with myelofibrosis and anemia

Results from VERIFY, a phase 3, double-blind, placebo (PBO)-controlled study of rusfertide for treatment of polycythemia vera (PV).

Rusfertide or placebo plus current standard-of-care therapy for polycythemia vera: Durability of response and safety results through week 52 from the randomized controlled phase 3 VERIFY study

Shorespan-007: Phase 3 study of bomedemstat versus hydroxyurea in essential thrombocythemia naive to cytoreductive therapy.

Shorespan-017: Phase 3 extension study for safety of bomedemstat in participants with essential thrombocythemia who received bomedemstat from a prior clinical study

Should dermatologic examinations become routine standard of care in patients with polycythemia vera? Observations from the phase 3 VERIFY study prior to rusfertide exposure

Ziftomenib in relapsed/refractory (R/R) <i>NPM1</i>-mutant acute myeloid leukemia (AML): Phase 1b/2 clinical activity and safety results from the pivotal KOMET-001 study.

Collaborators (12)

Vikas Gupta

Anao Zhang

Lydia Benitez

Russell J.H. Ryan

Lili Zhao

Florian Heidel

Malathi Kandarpa

gary luker

Harry P. Erba

Brian Ross

N Lynn Henry

Sunil Iyer

Make your next move.